Alan J. Russell Ph.D.
Net Worth

Last updated:

What is Alan J. Russell Ph.D. net worth?

The estimated net worth of Dr. Alan J. Russell Ph.D. is at least $10,851,918 as of 20 Sep 2024. He owns shares worth $167,318 as insider, has earned $8,759,600 from insider trading and has received compensation worth at least $1,925,000 in Edgewise Therapeutics, Inc..

What is the salary of Alan J. Russell Ph.D.?

Dr. Alan J. Russell Ph.D. salary is $481,250 per year as Co-Founder, Chief Scientific Officer & Director in Edgewise Therapeutics, Inc..

How old is Alan J. Russell Ph.D.?

Dr. Alan J. Russell Ph.D. is 55 years old, born in 1970.

What stocks does Alan J. Russell Ph.D. currently own?

As insider, Dr. Alan J. Russell Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Edgewise Therapeutics, Inc. (EWTX) Co-Founder, Chief Scientific Officer & Director 12,719 $13.16 $167,318

What does Edgewise Therapeutics, Inc. do?

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

EWTX logo
EWTX
Edgewise Therapeutics, Inc.
$13.16

Alan J. Russell Ph.D. insider trading

Edgewise Therapeutics, Inc.

Dr. Alan J. Russell Ph.D. has made 30 insider trades between 2021-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 172,585 units of EWTX stock on 30 Nov 2021. As of 20 Sep 2024 he still owns at least 12,719 units of EWTX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 75,000 $0.18 $13,500
Sale
Common Stock 74,185 $28.25 $2,096,023
Option
Common Stock 75,000 $0.18 $13,500
Sale
Common Stock 815 $29.51 $24,048
Sale
Common Stock 1,576 $18.91 $29,802
Option
Restricted Stock Units 5,208 N/A N/A
Option
Common Stock 5,208 N/A N/A
Sale
Common Stock 172,585 $9.33 $1,610,045
Sale
Common Stock 1,602 $8.91 $14,266
Option
Common Stock 5,208 N/A N/A
Option
Restricted Stock Units 5,208 N/A N/A
Option
Stock Option (Right to Buy) 172,585 $0.32 $54,364
Option
Common Stock 172,585 $0.32 $54,364
Sale
Common Stock 479 $19.34 $9,264
Sale
Common Stock 8,562 $19.51 $167,070
Sale
Common Stock 19,276 $20.12 $387,872
Sale
Common Stock 12,326 $19.96 $246,002
Sale
Common Stock 29,576 $20.12 $595,040
Sale
Common Stock 9,017 $20.17 $181,828
Sale
Common Stock 13,042 $20.16 $262,940
Sale
Common Stock 7,392 $19.76 $146,095
Sale
Common Stock 26,184 $18.75 $490,845
Sale
Common Stock 17,519 $17.43 $305,356
Sale
Common Stock 469 $18.03 $8,454
Sale
Common Stock 1,433 $18.07 $25,889
Sale
Common Stock 5,749 $18.18 $104,517
Sale
Common Stock 1,270 $18.02 $22,885
Sale
Common Stock 5,902 $18.15 $107,121
Sale
Common Stock 13,018 $18.56 $241,614
Sale
Common Stock 2,108 $18.03 $38,007
Sale
Common Stock 5,404 $18.26 $98,677
Sale
Common Stock 100 $18 $1,800
Sale
Common Stock 274 $18 $4,932
Sale
Common Stock 11,844 $17.15 $203,125
Sale
Common Stock 14,610 $17.3 $252,753
Sale
Common Stock 11,611 $18.23 $211,669
Sale
Common Stock 20,100 $18.16 $365,016
Sale
Common Stock 26,835 $18.88 $506,645

Edgewise Therapeutics key executives

Edgewise Therapeutics, Inc. executives and other stock owners filed with the SEC: